112 related articles for article (PubMed ID: 417410)
1. Intensive surgical and chemotherapeutic management of advanced ovarian cancer.
Griffiths CT; Fuller AF
Surg Clin North Am; 1978 Feb; 58(1):131-42. PubMed ID: 417410
[TBL] [Abstract][Full Text] [Related]
2. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.
Griffiths CT; Parker LM; Fuller AF
Cancer Treat Rep; 1979 Feb; 63(2):235-40. PubMed ID: 445502
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma.
Parker LM; Griffiths CT; Yankee RA; Canellos GP; Gelman R; Knapp RC; Richman CM; Tobias JS; Weiner RS; Frei E
Cancer; 1980 Aug; 46(4):669-74. PubMed ID: 7397632
[TBL] [Abstract][Full Text] [Related]
4. Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study.
Bolis G; Bortolozzi G; Carinelli G; D'Incalci M; Gramellini F; Morasca L; Mangioni C
Cancer Chemother Pharmacol; 1980; 4(2):129-32. PubMed ID: 7389058
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.
Edmonson JH; Fleming TR; Decker DG; Jorgensen EO; Malkasian GD; Jefferies JA; Kvols LK; Webb MJ
Recent Results Cancer Res; 1978; 68():157-9. PubMed ID: 752853
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy in the management of ovarian germ cell malignancies.
Schwartz PE
Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy in advanced ovarian cancer.
Smith JP; Rutledge FN
Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for stage III-IV ovarian cancer: the CAP-regimen in previously untreated patients.
Meerpohl HG; Pfleiderer A; Kleine W; Teufel G
Onkologie; 1982 Oct; 5(5):238-41. PubMed ID: 6760025
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary report on the treatment of ovarian cancer with adriamycin following full conventional treatment (author's transl)].
Wolf A; Vahrson H
Geburtshilfe Frauenheilkd; 1977 Mar; 37(3):224-7. PubMed ID: 858485
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer.
Rao B; Wanebo HJ; Ochoa M; Lewis JL; Oettgen HF
Cancer; 1977 Feb; 39(2):514-26. PubMed ID: 837334
[TBL] [Abstract][Full Text] [Related]
12. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
13. Impact of cisplatin multiagent chemotherapy and total parenteral hyperalimentation on bowel obstruction caused by ovarian cancer.
Tunca JC
Gynecol Oncol; 1981 Oct; 12(2 Pt 1):219-21. PubMed ID: 6795096
[No Abstract] [Full Text] [Related]
14. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
Ehrlich CE; Einhorn L; Stehman FB; Blessing J
Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
[No Abstract] [Full Text] [Related]
15. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer].
Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin in ovarian cancer patients resistant to cyclophosphamide.
Bolis G; D'Incalci M; Gramellini F; Mangioni C
Eur J Cancer (1965); 1978 Dec; 14(12):1401-2. PubMed ID: 738344
[No Abstract] [Full Text] [Related]
17. [Comparative study of different chemotherapy approaches for advanced epithelial ovarian cancer].
Chen YL; Liu YQ; Tang DH; Chu CN
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):110-4. PubMed ID: 18683749
[TBL] [Abstract][Full Text] [Related]
18. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
[No Abstract] [Full Text] [Related]
19. High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.
Lambert HE; Berry RJ
Br Med J (Clin Res Ed); 1985 Mar; 290(6472):889-93. PubMed ID: 3919831
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Barlow JJ; Piver MS
Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
